De Mossel 11a, 1723 HZ Noord-Scharwoude |
KYERON ©2007
ELIZ
bone graft substitute
ELIZ
is a sterile and reliable alternative for cancellous autograf
osteoconductive. The composition of ELIZ (60% HA and 40%
human bone and undergoes complete resorption at a controlled rate. Due to the similarity of the
interconnected structure with human cancellous bone, ELIZ provides an ide
new bone.
The porosity of ELIZ is 83%. This ultra high
throughout the pores. ELIZ will provide support without significantly limiting
natural bone density. Microporosity
assists the transfer of essential nutrients.
FEATURES
Proven biocompatibility and osteoconductivity
Osteoblastic activity is encourages by osteoclasti
phosphate ions locally
For easy handling, ELIZ granules can be mixed with blood, bone
marrow or platelet concentrate to form a cohesive mixture
ELIZ will integrate with new bon completely within 12
implant is than embedded within new bone forming bicontinuous matrix
INDICATIONS
ELIZ is indicated for use as a bone
graft substitute for the repair of
non-load bearing osseous defects.
Standard fixation techniques must
be used in load bearing
applications. ELIZ can be used for
fracture repair, non-unions, prosthesis revision surgery, spinal fusion, sinus lift and
other dental and periodontal procedures.
STUDY
Tests show that ELIZ implanted both in cancel
excellent osseointegration with rapid bone penetration through to the core of the
implant.
Comparing the use of a synthetic porous ceramic
like ELIZ with autogenous bone, t
comparable in both groups,
but complications occurred in relation to the
donor site of the bone graft.
Consequently can be concluded
safe and effective substitute for autograft.
t or allograft. It is biocompatible and
β-TCP) is similar to the mineral component of
al environment for the
porosity allows rapid bone ingrowth
(1.0 – 10um) within the HA/TCP structure
ELIZ is gamma sterilized
and available is several
volumes and sizes.
Supported by more
than 3000 publications
and over 500 clinical studies with respect to the
biocompatibility and clinical efficacy of HA and b
as bone substitute material, 25 years of successful use
is proven.
c resorption and phagocytosis, releasing calcium and
– 14 weeks. The
lous bone and cortical bone gives
he results were
that ceramic is a
Due to its similarity with human bone, no adverse reactions have ever
been reported. The calcium and phosphate resorption products are
beneficial in assisting local osteoblast activity at the site.
KDF004/02-00b
ingrowth of
-TCP
